SCHEMBL5508422

SCHEMBL5508422

CC(C)C(=O)Nc1ccc(F)c(C2CCN(CCCN(C(=O)Cc3ccccc3)C(=O)Cc3ccccc3)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.48
ADRA1A P35348 1/20 0.48
UBE2M P61081 1/20 0.46
DCUN1D1 Q96GG9 1/20 0.46
MCHR1 Q99705 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888061 0.91 DRD2 (0.51) DRD2ADRA1A
SCHEMBL5888272 0.88 DRD2 (0.44) DRD2
SCHEMBL5923589 0.87 UBE2M (0.49) DRD2UBE2MDCUN1D1
SCHEMBL4768518 0.86 DRD2 (0.47) DRD2
SCHEMBL5923658 0.85 DRD2 (0.48) DRD2ADRA1AMCHR1
SCHEMBL4764955 0.84 DRD2 (0.54) DRD2ADRA1A
SCHEMBL6000445 0.83 UBE2M (0.39) UBE2MDCUN1D1
SCHEMBL5888375 0.81 UBE2M (0.40) DRD2UBE2MDCUN1D1
SCHEMBL5508426 0.79 ADRA1D (0.56) ADRA1A
SCHEMBL5514989 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-20060217418-A1 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2006-09-28 US disclosed
US-7105544-B2 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-09-12 US disclosed
US-20060084649-A9 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-04-20 US disclosed
US-20060041139-A9 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. LUNDBECK A/S (DK) 2006-02-23 US disclosed
US-20040186103-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-09-23 US disclosed
US-20040073036-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073036-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885UBE2M 3996/4885
US-20060084649-A9 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885UBE2M 3996/4885
US-20060041139-A9 SUBSTITUTED ALKYL AMIDO PIPERIDINES MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885UBE2M 3996/4885
US-20060217418-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885UBE2M 3996/4885
US-20040186103-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885UBE2M 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.